Complications associated with use of bone-morphogenetic proteins in spinal fusion procedures

JAMA. 2009 Nov 18;302(19):2090-1; author reply 2091. doi: 10.1001/jama.2009.1639.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Bone Morphogenetic Proteins / adverse effects
  • Bone Morphogenetic Proteins / therapeutic use*
  • Humans
  • Postoperative Complications / epidemiology*
  • Risk Assessment
  • Spinal Fusion*

Substances

  • Bone Morphogenetic Proteins